Scientists test 'Double-Edged' gene therapy to fight HIV and cancer at once
NCT ID NCT02337985
Summary
This early-stage study is testing a two-part treatment for people with AIDS-related lymphoma. First, patients receive standard chemotherapy to fight the cancer. Then, they receive an infusion of their own blood stem cells that have been genetically modified in a lab to resist HIV. The main goal is to see if this combined approach is safe and feasible, with the hope it could help the body better control both HIV and the cancer long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NCI Lymphoid Malignancies Branch
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.